Back

Clinical outcomes according to clinical and surgical risk scores for tricuspid regurgitation

31 August 2024 (13:55 - 14:05)
Organised by: Logo
Congress Presentation Part of: Tricuspid valve intervention: ready for prime time? Surgery ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Assistant Professor Seo-Yeon Gwak

Yonsei University College of Medicine, Seoul (Korea (Republic of))

5 More presentations in this session

Presentation thumbnail
Echocardiographic pulmonary vascular resistance in patients undergoing tricuspid annuloplasty: prognostic implications and reversibility
Mr J. Zhang (Hong Kong, CN)
Abstract Slides Video
Presentation thumbnail
Characteristics and outcomes of patients with moderate multivalvular disease in the context of tricuspid regurgitation
Doctor M. Morosato (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Ventricular interaction and clinical outcomes in patients undergoing transcatheter tricuspid valve repair
Doctor T. Tanaka (Kawasaki, JP)
Abstract Slides Video
Presentation thumbnail
Different right ventricular mechanics in atrial and ventricular secondary tricuspid regurgitation and their prognostic role. A multicentric three-dimensional echocardiography study
Doctor B. Lakatos (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Mortality rates by therapeutic approaches for isolated severe tricuspid regurgitation: a systematic review.
Doctor J. Mesnier (Paris, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Tricuspid valve intervention: ready for prime time?
Video

The Event

Event poster

ESC Congress 2024

31 August 2024 13:55 CET
You may be interested in
thumbnail
Congress Presentation
Long-term benefit of isolated surgical tricuspid valve repair and replacement in patients with severe functional tricuspid regurgitation: Impact of the TRI-SCORE
thumbnail
Congress Presentation
Timing of intervention in patients with severe tricuspid regurgitation
thumbnail
Congress Presentation
Risk scores: can they determine who should and should not undergo transcatheter interventions?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources